Advertisement

Topics

FDA Prioritizes ANDAs Ready For Launch After 180-Day Exclusivity Expires

13:42 EST 9 Nov 2017 | SCRIP

In effort to speed competition and lower drug prices, US regulator will prioritize review of generic drug applications likely to...

      

Related Stories

 

Original Article: FDA Prioritizes ANDAs Ready For Launch After 180-Day Exclusivity Expires

NEXT ARTICLE

More From BioPortfolio on "FDA Prioritizes ANDAs Ready For Launch After 180-Day Exclusivity Expires"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...